Publications by authors named "Olaf Hars"

Claim this Profile
C
Correction to: Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up.
Ioannis Kyvernitakis, Thea Charlott Reuter, Lars Hellmeyer, Olaf Hars, Peyman Hadji

Osteoporos Int· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Early Breast Cancer, the Ratios of Neutrophils, Platelets and Monocytes to Lymphocytes Significantly Correlate with the Presence of Subsets of Circulating Tumor Cells but Not with Disseminated Tumor Cells.
Sabine Kasimir-Bauer, Ebru Karaaslan, Olaf Hars, Oliver Hoffmann, Rainer Kimmig

Cancers (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical experience with misoprostol vaginal insert for induction of labor: a prospective clinical observational study.
Markus Schmidt, Maria Neophytou, Olaf Hars, Julia Freudenberg, Maritta Kühnert

Arch Gynecol Obstet· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of breast cancer treatment-induced bone loss in premenopausal women treated with zoledronic acid: Final 5-year results from the randomized, double-blind, placebo-controlled ProBONE II trial.
Ioannis Kyvernitakis, Peter Herbert Kann, Friederike Thomasius, Olaf Hars, Peyman Hadji

Bone· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy-associated transient osteoporosis of the hip: results of a case-control study.
Peyman Hadji, Jelena Boekhoff, Melitta Hahn, Lars Hellmeyer, Olaf Hars

Arch Osteoporos· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of aromatase inhibition on serum levels of sclerostin and dickkopf-1, bone turnover markers and bone mineral density in women with breast cancer.
Ioannis Kyvernitakis, Tilman D Rachner, Anja Urbschat, Olaf Hars, Lorenz C Hofbauer

J Cancer Res Clin Oncol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment--the COMPAS study.
Volker Ziller, Ioannis Kyvernitakis, Dana Knöll, Astrid Storch, Olaf Hars

BMC Cancer· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of compliance on bone mineral density changes in postmenopausal women with early breast cancer on Anastrozole.
Matthias Kalder, Volker Ziller, Ioannis Kyvernitakis, Dana Knöll, Olaf Hars

J Cancer Res Clin Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for antiresorptive therapy in postmenopausal patients with breast cancer: Marburg AIBL Guideline Evaluation Study (MAGES).
Peyman Hadji, Melanie Hartenfels, Jannis Kyvernitakis, Olaf Hars, Klaus Heinrich Baumann

Breast Cancer Res Treat· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of plasma carboxy-terminal cross-linking telopeptide of type I collagen concentration in horses.
Bianca Carstanjen, Nicholas R Hoyle, Annick Gabriel, Olaf Hars, Charlotte Sandersen

Am J Vet Res· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-associated changes in bone ultrasonometry of the os calcis.
Peyman Hadji, Mathias Kalder, J Backhus, May Gottschalk, Olaf Hars

J Clin Densitom· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis